Trombly Amy Moss
Sonoma Pharmaceuticals, Inc. · Chief Executive Officer
Trombly Amy Moss is listed in filings as Chief Executive Officer at Sonoma Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 2, 2026, including 4 public disclosures. Recent filings connect the profile to Sonoma Pharmaceuticals, Inc. (SNOA). The current snapshot covers public activity from Jun 21, 2024 to Jan 2, 2026. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||